Results 221 to 230 of about 174,958 (266)
Some of the next articles are maybe not open access.
Varicocele - a historical perspective
World Journal of Urology, 1999Varicocele is an essential part of andrological urology. Due to its frequency and to the problems connected with it, varicocele became a subject of interest at an early stage in the history of medicine. Questions arose as to how the changes and the consequences resulting from this condition should be treated.
H D, Nöske, W, Weidner
openaire +2 more sources
Blinatumomab: A historical perspective
Pharmacology & Therapeutics, 2012For decades, chemotherapy has been the backbone for the treatment of patients with B cell malignancies. Depending on the individual disease, monoclonal antibodies, irradiation and/or hematopoietic stem cell transplantation are added. However, the current standard of care--particularly for patients with relapsed disease--is often not sufficient to ...
Dirk, Nagorsen +3 more
openaire +2 more sources
A Historical Perspective of Laminitis
Veterinary Clinics of North America: Equine Practice, 2010The causes of laminitis are many-often interrelated, sometimes direct opposites. The history of laminitis has been a search for the cause or causes of laminitis and for effective treatment. Going in and out of fashion, many treatments have lasted for centuries, some for millennia, but very few have been proven.
openaire +2 more sources
The SSEC in Historical Perspective
IEEE Annals of the History of Computing, 1982The Selective Sequence Electronic Calculator (SSEC) was the first machine to combine electronic computation with a stored program, and the first machine capable of operating on its own instructions as data. When placed in operation in 1948, and for some time thereafter, it was the most flexible and powerful computer in existence.
openaire +2 more sources
Sarcoidosis: a historical perspective
Clinics in Dermatology, 2007Sarcoidosis is a malady that generates immense interest and anxiety among the sufferers and their care providers. This commonplace inflammatory disease also engenders enthusiastic controversy among those who study its cause and causation. Sarcoidosis has been with us for more than 150 years.
openaire +2 more sources
Pharmacoeconomics: Historical Perspective
Annals of Pharmacotherapy, 20062006 marks the 40th year of publication for The Annals. Over that time, The Annals has been an important contributor to the development of clinical pharmacy. Throughout 2006, we are publishing articles reflecting on the history of clinical pharmacy through the eyes of practitioners, including those pioneering clinical pharmacy, as well as those who ...
J Lyle, Bootman +2 more
openaire +2 more sources
Nanoparticles—a historical perspective
International Journal of Pharmaceutics, 2007The historical development of nanoparticles starting with Paul Ehrlich and then first attempts by Ursula Scheffel and colleagues and the extensive work by the group of Professor Peter Speiser at the ETH Zürich in the late 1960s and early 1970s are described from a personal point of view.
openaire +2 more sources
Perspective on historical perspectives
Journal of Applied Physiology, 2000a number of changes have been initiated in the Journal of Applied Physiology by the new editor, Gary Sieck, and among these is a plan to have occasional papers on historical topics in physiology.
John B. West, consulting editor
openaire +2 more sources
Historical Perspectives on Dyslexia
Journal of Learning Disabilities, 1992This article begins with an historical overview of the neurological aspects of dyslexia, which was originally seen as a member of the family of aphasias. That overview is followed by a brief review of familial and genetic factors in developmental dyslexia.
openaire +2 more sources
Laetrile in Historical Perspective
2019Laetrile's history has been complex, tortuous, and kaleidoscopic. Two men, each named Ernst T. Krebs, father and son, bring Laetrile to market and dominate its early years. Their backgrounds may prove instructive. In the intervening years Dr. Krebs had continued to seek new therapeutic entities.
openaire +2 more sources